NoMo Diagnostics
8 News & Press Releases found
NoMo Diagnostics news
Recent article (here) reviews technology platform which could become the gold standard in diagnosing concussion on the field.
Oct. 11, 2022
An algorithm has been proposed for negotiating the discussion (here)
Oct. 11, 2022
Our CMO, Dr. James Noble, shares clinical insight into how concussions present in soccer (here). There is a need for more research and improved diagnostic devices for real-time monitoring of athletes.
Oct. 11, 2022
“NoMo Diagnostics is developing what it hopes will be the first FDA-approved, real-time concussion detector to facilitate early recognition and treatment.”
Oct. 11, 2022
An interview with the lead author from The American Journal of Sports Medicine, Effects of the New York State Concussion Management and Awareness Act (“Lystedt Law”) on Concussion-Related Emergency Health Care Utilization Among Adolescents, 2005-2015 (here). More on Zack Lystadt`s concussion survivor`s journey (here).
Oct. 11, 2022
In a 15-year retrospective study (here) of 1,200 varsity student-athletes at Columbia University in New York, Dr. James Noble, NoMo Diagnostics CMO, found: the most commonly reported concussion symptoms include headache, impaired concentration, and dizziness; the risk of concussion was higher among females (23.3 percent) than males (17 percent) over the course of their collegiate career; an
Oct. 11, 2022
Smart helmets with embedded brainwave monitoring technology will automate the detection of concussions for caregivers on the sidelines. There is a high unmet need that is not properly addressed by motion sensors which have proven to be clinically unreliable in monitoring brain injury. Find out more about NoMo technology (here).
Oct. 11, 2022
Walter Isaacson talks with sports injury experts about how medical professionals are using new technologies and advanced training to keep athletes in the game (here at 14:40). Smart health helmets bring the
Oct. 11, 2022
